Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oseltamivir plus antibiotics for severe sepsis with thrombocytopenia
ChiCTR-IPR-16008542Phase 4Recruiting
- Sponsor
- Qilu Hospital of Shandong University
- Start
- Mar 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of oseltamivir in sepsis and Thrombocytopenia (2 arms), sponsored by Qilu Hospital of Shandong University. Primary endpoints: platelet desialylation level, platelet overall response and 1 more. Started Mar 2014; status: recruiting.
02
Drugs
oseltamivir
03
Conditions
sepsisThrombocytopenia
Beyond the preview
Go deeper on ChiCTR-IPR-16008542.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-16008542.